Intracellular amyloid-β in Alzheimer's disease (original) (raw)

• Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und Psychisch-Gerichtliche Medizine 64, 146–148 (1907).
  Google Scholar
• Glenner, G. G. & Wong, C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885–890 (1984).
  Article CAS PubMed Google Scholar
• Masters, C. L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 82, 4245–4249 (1985).
  Article CAS PubMed PubMed Central Google Scholar
• Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E. & Klug, A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl Acad. Sci. USA 85, 4051–4055 (1988).
  Article CAS PubMed PubMed Central Google Scholar
• Grundke-Iqbal, I. et al. Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA 83, 4913–4917 (1986).
  Article CAS PubMed PubMed Central Google Scholar
• Ihara, Y., Nukina, N., Miura, R. & Ogawara, M. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J. Biochem. (Tokyo) 99, 1807–1810 (1986).
  Article CAS Google Scholar
• Kosik, K. S., Joachim, C. L. & Selkoe, D. J. Microtubule-associated protein tau (τ) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl Acad. Sci. USA 83, 4044–4048 (1986).
  Article CAS PubMed PubMed Central Google Scholar
• Rozemuller, J. M., Eikelenboom, P. & Stam, F. C. Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study. Virchows Arch. B Cell Pathol. 51, 247–254 (1986).
  Article CAS Google Scholar
• Wyss-Coray, T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nature Med. 12, 1005–1015 (2006).
  CAS PubMed Google Scholar
• Markesbery, W. R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134–147 (1997).
  Article CAS PubMed Google Scholar
• McGeer, P. L., Rogers, J. & McGeer, E. G. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J. Alzheimers Dis. 9, 271–276 (2006).
  Article CAS PubMed Google Scholar
• Allinson, T. M., Parkin, E. T., Turner, A. J. & Hooper, N. M. ADAMs family members as amyloid precursor protein α-secretases. J. Neurosci. Res. 74, 342–352 (2003).
  Article CAS PubMed Google Scholar
• Vassar, R. et al. β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735–741 (1999).
  Article CAS PubMed Google Scholar
• Hussain, I. et al. Identification of a novel aspartic protease (Asp 2) as β-secretase. Mol. Cell. Neurosci. 14, 419–427 (1999).
  Article CAS PubMed Google Scholar
• Sinha, S. et al. Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature 402, 537–540 (1999).
  Article CAS PubMed Google Scholar
• Wolfe, M. S. et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398, 513–517 (1999).
  Article CAS PubMed Google Scholar
• Steiner, H. et al. PEN-2 is an integral component of the γ-secretase complex required for coordinated expression of presenilin and nicastrin. J. Biol. Chem. 277, 39062–39065 (2002).
  Article CAS PubMed Google Scholar
• Francis, R. et al. aph-1 and pen-2 are required for Notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation. Dev. Cell 3, 85–97 (2002).
  Article CAS PubMed Google Scholar
• Levitan, D. et al. PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling. Proc. Natl Acad. Sci. USA 98, 12186–12190 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, G. et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing. Nature 407, 48–54 (2000).
  Article CAS PubMed Google Scholar
• Kojro, E. & Fahrenholz, F. The non-amyloidogenic pathway: structure and function of α-secretases. Subcell. Biochem. 38, 105–127 (2005).
  Article CAS PubMed Google Scholar
• Haass, C., Hung, A. Y., Schlossmacher, M. G., Teplow, D. B. & Selkoe, D. J. β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 3021–3024 (1993).
  Article CAS PubMed Google Scholar
• Jarrett, J. T., Berger, E. P. & Lansbury, P. T. Jr. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693–4697 (1993).
  Article CAS PubMed Google Scholar
• Younkin, S. G. The role of Aβ 42 in Alzheimer's disease. J. Physiol. Paris 92, 289–292 (1998).
  Article CAS PubMed Google Scholar
• St George-Hyslop, P. H. & Petit, A. Molecular biology and genetics of Alzheimer's disease. C. R. Biol. 328, 119–130 (2005).
  Article CAS PubMed Google Scholar
• Haass, C. et al. The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway. Nature Med. 1, 1291–1296 (1995).
  Article CAS PubMed Google Scholar
• Nilsberth, C. et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nature Neurosci. 4, 887–893 (2001).
  Article CAS PubMed Google Scholar
• Guo, Q. et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nature Med. 5, 101–106 (1999).
  Article CAS PubMed Google Scholar
• Jankowsky, J. L. et al. Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase. Hum. Mol. Genet. 13, 159–170 (2004).
  Article CAS PubMed Google Scholar
• Rovelet-Lecrux, A. et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nature Genet. 38, 24–26 (2006).
  Article CAS PubMed Google Scholar
• Cabrejo, L. et al. Phenotype associated with APP duplication in five families. Brain 129, 2966–2976 (2006).
  Article PubMed Google Scholar
• Gyure, K. A., Durham, R., Stewart, W. F., Smialek, J. E. & Troncoso, J. C. Intraneuronal Aβ-amyloid precedes development of amyloid plaques in Down syndrome. Arch. Pathol. Lab. Med. 125, 489–492 (2001).
  Article CAS PubMed Google Scholar
• Mori, C. et al. Intraneuronal Aβ42 accumulation in Down syndrome brain. Amyloid 9, 88–102 (2002).
  Article CAS PubMed Google Scholar
• Grundke-Iqbal, I. et al. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc. Natl Acad. Sci. USA 86, 2853–2857 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Blurton-Jones, M. & Laferla, F. M. Pathways by which Aβ facilitates tau pathology. Curr. Alzheimer Res. 3, 437–448 (2006).
  Article CAS PubMed Google Scholar
• Gouras, G. K. et al. Intraneuronal Aβ42 accumulation in human brain. Am. J. Pathol. 156, 15–20 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Takahashi, R. H. et al. Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161, 869–1879 (2002). Using electron microscope analysis, this paper shows that in AD brains, intraneuronal Aβ accumulates within the multivesicular bodies.
  Article Google Scholar
• D'Andrea, M. R. et al. The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations. Neurosci. Lett. 342, 114–118 (2003).
  Article CAS PubMed Google Scholar
• Ohyagi, Y. et al. Intraneuronal amyloid β42 enhanced by heating but counteracted by formic acid. J. Neurosci. Methods 159, 134–138 (2007).
  Article CAS PubMed Google Scholar
• Chui, D. H. et al. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nature Med. 5, 560–564 (1999).
  Article CAS PubMed Google Scholar
• Knobloch, M., Konietzko, U., Krebs, D. C. & Nitsch, R. M. Intracellular Aβ and cognitive deficits precede β-amyloid deposition in transgenic arcAβ mice. Neurobiol. Aging, 31 July 2006 (doi:10.1016/j.neurobiolaging.2006.06.019). Provides evidence linking intraneuronal Aβ accumulation to cognitive deficits in transgenic mice.
  Article CAS PubMed Google Scholar
• Kuo, Y. M. et al. The evolution of Aβ peptide burden in the APP23 transgenic mice: implications for Aβ deposition in Alzheimer disease. Mol. Med. 7, 609–618 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Li, Q. X. et al. Intracellular accumulation of detergent-soluble amyloidogenic Aβ fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice. J. Neurochem. 72, 2479–2487 (1999).
  Article CAS PubMed Google Scholar
• Lord, A. et al. The Arctic Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in transgenic mice. Neurobiol. Aging 27, 67–77 (2006).
  Article CAS PubMed Google Scholar
• Oakley, H. et al. Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129–10140 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Oddo, S. et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39, 409–421 (2003). Provides the earliest in vivo evidence that links intraneuronal Aβ to synaptic dysfunction, showing that intraneuronal Aβ accumulation leads to a profound LTP deficit in 3xTg-AD mice.
  Article CAS PubMed Google Scholar
• Wirths, O. et al. Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 306, 116–120 (2001).
  Article CAS PubMed Google Scholar
• Oddo, S., Caccamo, A., Smith, I. F., Green, K. N. & LaFerla, F. M. A dynamic relationship between intracellular and extracellular pools of Aβ. Am. J. Pathol. 168, 184–194 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Wegiel, J. et al. Intraneuronal Aβ immunoreactivity is not a predictor of brain amyloidosis-β or neurofibrillary degeneration. Acta Neuropathol. (Berl) 113, 389–402 (2007).
  Article CAS Google Scholar
• Kinoshita, A. et al. Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. J. Cell Sci. 116, 3339–3346 (2003).
  Article CAS PubMed Google Scholar
• Breen, K. C., Bruce, M. & Anderton, B. H. β amyloid precursor protein mediates neuronal cell–cell and cell–surface adhesion. J. Neurosci. Res. 28, 90–100 (1991).
  Article CAS PubMed Google Scholar
• Sabo, S. L., Ikin, A. F., Buxbaum, J. D. & Greengard, P. The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J. Cell Biol. 153, 1403–1414 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Xu, H., Greengard, P. & Gandy, S. Regulated formation of Golgi secretory vesicles containing Alzheimer β-amyloid precursor protein. J. Biol. Chem. 270, 23243–23245 (1995).
  Article CAS PubMed Google Scholar
• Mizuguchi, M., Ikeda, K. & Kim, S. U. Differential distribution of cellular forms of β-amyloid precursor protein in murine glial cell cultures. Brain Res. 584, 219–225 (1992).
  Article CAS PubMed Google Scholar
• Wertkin, A. M. et al. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc. Natl Acad. Sci. USA 90, 9513–9517 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Martin, B. L. et al. Intracellular accumulation of β-amyloid in cells expressing the Swedish mutant amyloid precursor protein. J. Biol. Chem. 270, 26727–26730 (1995).
  Article CAS PubMed Google Scholar
• Rogaeva, E. et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nature Genet. 39, 168–177 (2007).
  Article CAS PubMed Google Scholar
• Golde, T. E., Estus, S., Younkin, L. H., Selkoe, D. J. & Younkin, S. G. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255, 728–730 (1992).
  Article CAS PubMed Google Scholar
• Koo, E. H. & Squazzo, S. L. Evidence that production and release of amyloid β-protein involves the endocytic pathway. J. Biol. Chem. 269, 17386–17389 (1994).
  Article CAS PubMed Google Scholar
• Perez, R. G. et al. Mutagenesis identifies new signals for β-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Aβ42. J. Biol. Chem. 274, 18851–18856 (1999).
  Article CAS PubMed Google Scholar
• Cam, J. A. et al. The low density lipoprotein receptor-related protein 1B retains β-amyloid precursor protein at the cell surface and reduces amyloid-β peptide production. J. Biol. Chem. 279, 29639–29646 (2004).
  Article CAS PubMed Google Scholar
• Busciglio, J., Gabuzda, D. H., Matsudaira, P. & Yankner, B. A. Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl Acad. Sci. USA 90, 2092–2096 (1993). Provides strong evidence that Aβ in neurons is generated by the secretory pathway.
  Article CAS PubMed PubMed Central Google Scholar
• Cook, D. G. et al. Alzheimer's A β(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nature Med. 3, 1021–1023 (1997).
  Article CAS PubMed Google Scholar
• Lee, S. J. et al. A detergent-insoluble membrane compartment contains A β in vivo. Nature Med. 4, 730–734 (1998).
  Article CAS PubMed Google Scholar
• Skovronsky, D. M., Doms, R. W. & Lee, V. M. Detection of a novel intraneuronal pool of insoluble amyloid β protein that accumulates with time in culture. J. Cell Biol. 141, 1031–1039 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Wild-Bode, C. et al. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J. Biol. Chem. 272, 16085–16088 (1997).
  Article CAS PubMed Google Scholar
• Hartmann, T. et al. Distinct sites of intracellular production for Alzheimer's disease A β40/42 amyloid peptides. Nature Med. 3, 1016–10120 (1997). Shows that both Aβ 40 and Aβ 42 are generated intracellularly but at different sites.
  Article CAS PubMed Google Scholar
• Bu, G., Cam, J. & Zerbinatti, C. LRP in amyloid-β production and metabolism. Ann. N. Y. Acad. Sci. 1086, 35–53 (2006).
  Article CAS PubMed Google Scholar
• Deane, R. et al. RAGE mediates amyloid-β peptide transport across the blood–brain barrier and accumulation in brain. Nature Med. 9, 907–913 (2003).
  Article CAS PubMed Google Scholar
• Nagele, R. G., D'Andrea, M. R., Anderson, W. J. & Wang, H. Y. Intracellular accumulation of β-amyloid1–42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110, 199–211 (2002). Shows that Aβ binds to α7nAChR and suggests that it is subsequently internalized, thus providing a mechanism for intraneuronal Aβ accumulation.
  Article CAS PubMed Google Scholar
• Yazawa, H. et al. β amyloid peptide (Aβ42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J. 15, 2454–2462 (2001).
  Article CAS PubMed Google Scholar
• Clifford, P. M. et al. Aβ peptides can enter the brain through a defective blood–brain barrier and bind selectively to neurons. Brain Res. 1142, 223–236 (2007).
  Article CAS PubMed Google Scholar
• Wang, H. Y. et al. β-Amyloid1–42 binds to α7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J. Biol. Chem. 275, 5626–5632 (2000).
  Article CAS PubMed Google Scholar
• Oddo, S. et al. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 102, 3046–3051 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Zerbinatti, C. V. et al. Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Aβ42 accumulation in amyloid model mice. J. Biol. Chem. 281, 36180–36186 (2006).
  Article CAS PubMed Google Scholar
• Yan, S. D. et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685–691 (1996).
  Article CAS PubMed Google Scholar
• Sasaki, N. et al. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res. 888, 256–262 (2001).
  Article CAS PubMed Google Scholar
• Du Yan, S. et al. Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl Acad. Sci. USA 94, 5296–5301 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Iribarren, P., Zhou, Y., Hu, J., Le, Y. & Wang, J. M. Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease. Immunol. Res. 31, 165–176 (2005).
  Article CAS PubMed Google Scholar
• Snyder, E. M. et al. Regulation of NMDA receptor trafficking by amyloid-β. Nature Neurosci. 8, 1051–1058 (2005).
  Article CAS PubMed Google Scholar
• Bi, X., Gall, C. M., Zhou, J. & Lynch, G. Uptake and pathogenic effects of amyloid β peptide 1–42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists. Neuroscience 112, 827–840 (2002).
  Article CAS PubMed Google Scholar
• Reisberg, B. et al. Memantine in moderate-to-severe Alzheimer's disease. N. Engl. J. Med. 348, 1333–1341 (2003).
  Article CAS PubMed Google Scholar
• Minkeviciene, R., Banerjee, P. & Tanila, H. Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease. J. Pharmacol. Exp. Ther. 311, 677–682 (2004).
  Article CAS PubMed Google Scholar
• Cleary, J. P. et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nature Neurosci. 8, 79–84 (2005).
  Article CAS PubMed Google Scholar
• Walsh, D. M. et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535–539 (2002).
  Article CAS PubMed Google Scholar
• Lesne, S. et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352–357 (2006).
  Article CAS PubMed Google Scholar
• Walsh, D. M., Tseng, B. P., Rydel, R. E., Podlisny, M. B. & Selkoe, D. J. The oligomerization of amyloid β-protein begins intracellularly in cells derived from human brain. Biochemistry 39, 10831–10839 (2000). Using cells from the human brain, this paper shows that Aβ oligomerization starts intraneuronally.
  Article CAS PubMed Google Scholar
• Oddo, S. et al. Temporal profile of amyloid-β (Aβ) oligomerization in an in vivo model of Alzheimer disease. A link between Aβ and tau pathology. J. Biol. Chem. 281, 1599–1604 (2006).
  Article CAS PubMed Google Scholar
• Takahashi, R. H. et al. Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain. J. Neurosci. 24, 3592–3599 (2004). Shows that Aβ oligomers accumulate intraneuronally in AD brain.
  Article CAS PubMed PubMed Central Google Scholar
• Kim, S. I., Yi, J. S. & Ko, Y. G. Amyloid β oligomerization is induced by brain lipid rafts. J. Cell Biochem. 99, 878–889 (2006).
  Article CAS PubMed Google Scholar
• Kawarabayashi, T. et al. Dimeric amyloid β protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 24, 3801–3809 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Waschuk, S. A., Elton, E. A., Darabie, A. A., Fraser, P. E. & McLaurin, J. A. Cellular membrane composition defines Aβ-lipid interactions. J. Biol. Chem. 276, 33561–33568 (2001).
  Article CAS PubMed Google Scholar
• Matsuzaki, K. et al. Inhibitors of amyloid β-protein aggregation mediated by GM1-containing raft-like membranes. Biochim. Biophys. Acta 1768, 122–130 (2007).
  Article CAS PubMed Google Scholar
• Wakabayashi, M., Okada, T., Kozutsumi, Y. & Matsuzaki, K. GM1 ganglioside-mediated accumulation of amyloid β-protein on cell membranes. Biochem. Biophys. Res. Commun. 328, 1019–1023 (2005).
  Article CAS PubMed Google Scholar
• Yamamoto, N. et al. Accelerated Aβ aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain. FEBS Lett. 569, 135–139 (2004).
  Article CAS PubMed Google Scholar
• D'Andrea, M. R., Nagele, R. G., Wang, H. Y., Peterson, P. A. & Lee, D. H. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38, 120–134 (2001). Provides evidence suggesting that in the brains of patients with AD, intracellular Aβ accumulation may lead to neuronal death, and that after being released in the extracellular compartment, it can contribute to the formation of plaques.
  Article CAS PubMed Google Scholar
• Bahr, B. A. et al. Amyloid β protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J. Comp. Neurol. 397, 139–147 (1998).
  Article CAS PubMed Google Scholar
• Schenk, D. et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177 (1999).
  Article CAS PubMed Google Scholar
• Janus, C. et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979–982 (2000).
  Article CAS PubMed Google Scholar
• Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H. & LaFerla, F. M. Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321–332 (2004). Shows that Aβ immunotherapy clears intraneuronal Aβ accumulation, which leads to the removal of tau deposits, thus linking intracellular Aβ and tau pathology.
  Article CAS PubMed Google Scholar
• Gouras, G. K., Almeida, C. G. & Takahashi, R. H. Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease. Neurobiol. Aging 26, 1235–1244 (2005).
  Article CAS PubMed Google Scholar
• Tseng, B. P., Kitazawa, M. & LaFerla, F. M. Amyloid β-peptide: the inside story. Curr. Alzheimer Res. 1, 231–239 (2004).
  Article CAS PubMed Google Scholar
• Langui, D. et al. Subcellular topography of neuronal Aβ peptide in APPxPS1 transgenic mice. Am. J. Pathol. 165, 1465–1477 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Almeida, C. G., Takahashi, R. H. & Gouras, G. K. β-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin–proteasome system. J. Neurosci. 26, 4277–4288 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Gregori, L., Fuchs, C., Figueiredo-Pereira, M. E., Van Nostrand, W. E. & Goldgaber, D. Amyloid β-protein inhibits ubiquitin-dependent protein degradation in vitro. J. Biol. Chem. 270, 19702–19708 (1995).
  Article CAS PubMed Google Scholar
• Oh, S. et al. Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech. Ageing Dev. 126, 1292–1299 (2005).
  Article CAS PubMed Google Scholar
• Tseng, B. P., Green, K. N., Chan, J., Blurton-Jones, M. & LaFerla, F. Aβ inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol. Aging (in the press).
• Manczak, M. et al. Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15, 1437–1449 (2006).
  Article CAS PubMed Google Scholar
• Hansson, C. A. et al. Nicastrin, presenilin, APH-1, and PEN-2 form active γ-secretase complexes in mitochondria. J. Biol. Chem. 279, 51654–51660 (2004).
  Article CAS PubMed Google Scholar
• Caspersen, C. et al. Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 19, 2040–2041 (2005).
  Article CAS PubMed Google Scholar
• Keil, U. et al. Mitochondrial dysfunction induced by disease relevant AβPP and tau protein mutations. J. Alzheimers Dis. 9, 139–146 (2006).
  Article PubMed Google Scholar
• Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L. & LaFerla, F. M. Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675–688 (2005). Shows that intraneuronal Aβ accumulation is responsible for the onset of cognitive decline in the 3xTg-AD.
  Article CAS PubMed Google Scholar
• Morris, R. G., Anderson, E., Lynch, G. S. & Baudry, M. Selective impairment of learning and blockade of long-term potentiation by an _N_-methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774–776 (1986).
  Article CAS PubMed Google Scholar
• Gong, B. et al. Ubiquitin hydrolase Uch-L1 rescues β-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775–788 (2006).
  Article CAS PubMed Google Scholar
• Green, K. N. et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-β and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci. 27, 4385–4395 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Hashimoto, M. et al. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid β-infused rats. J. Nutr. 135, 549–555 (2005).
  Article CAS PubMed Google Scholar
• Lim, G. P. et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J. Neurosci. 25, 3032–3040 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Gasparini, L. et al. Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling. J. Neurosci. 21, 2561–2570 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Billings, L. M., Green, K. N., McGaugh, J. L. & LaFerla, F. M. Learning decreases Aβ*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice. J. Neurosci. 27, 751–761 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Green, K. N., Billings, L. M., Roozendaal, B., McGaugh, J. L. & LaFerla, F. M. Glucocorticoids increase amyloid-β and tau pathology in a mouse model of Alzheimer's disease. J. Neurosci. 26, 9047–9056 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Sparks, D. L. et al. Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126, 88–94 (1994).
  Article CAS PubMed Google Scholar
• Misonou, H., Morishima-Kawashima, M. & Ihara, Y. Oxidative stress induces intracellular accumulation of amyloid β-protein (Aβ) in human neuroblastoma cells. Biochemistry 39, 6951–6959 (2000).
  Article CAS PubMed Google Scholar
• Hasegawa, T. et al. Homocysteic acid induces intraneuronal accumulation of neurotoxic Aβ42: implications for the pathogenesis of Alzheimer's disease. J. Neurosci. Res. 80, 869–876 (2005).
  Article CAS PubMed Google Scholar
• D'Andrea, M. R., Nagele, R. G., Wang, H. Y. & Lee, D. H. Consistent immunohistochemical detection of intracellular β-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex. Neurosci. Lett. 333, 163–166 (2002).
  Article CAS PubMed Google Scholar
• D'Andrea, M. R. et al. Lipofuscin and Aβ42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains. Neurosci. Lett. 323, 45–49 (2002).
  Article CAS PubMed Google Scholar
• LaFerla, F. M., Troncoso, J. C., Strickland, D. K., Kawas, C. H. & Jay, G. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Aβ stabilization. J. Clin. Invest. 100, 310–320 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Mochizuki, A., Tamaoka, A., Shimohata, A., Komatsuzaki, Y. & Shoji, S. Aβ42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease. Lancet 355, 42–43 (2000).
  Article CAS PubMed Google Scholar
• Mendell, J. R., Sahenk, Z., Gales, T. & Paul, L. Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. Arch. Neurol. 48, 1229–1234 (1991).
  Article CAS PubMed Google Scholar
• Sarkozi, E., Askanas, V., Johnson, S. A., Engel, W. K. & Alvarez, R. B. β-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. Neuroreport 4, 815–818 (1993).
  Article CAS PubMed Google Scholar
• Askanas, V., Engel, W. K. & Alvarez, R. B. Enhanced detection of congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique. Neurology 43, 1265–1267 (1993).
  Article CAS PubMed Google Scholar
• Kimura, N. et al. Age-related changes of intracellular Aβ in cynomolgus monkey brains. Neuropathol. Appl. Neurobiol. 31, 170–180 (2005).
  Article CAS PubMed Google Scholar
• Martin, L. J., Pardo, C. A., Cork, L. C. & Price, D. L. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145, 1358–1381 (1994).
  CAS PubMed PubMed Central Google Scholar
• Cummings, B. J., Su, J. H., Cotman, C. W., White, R. & Russell, M. J. β-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease. Neurobiol. Aging 14, 547–560 (1993).
  Article CAS PubMed Google Scholar
• Torp, R. et al. Ultrastructural evidence of fibrillar β-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains. Neuroscience 96, 495–506 (2000).
  Article CAS PubMed Google Scholar
• Cruz, J. C. et al. p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid β in vivo. J. Neurosci. 26, 10536–10541 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Casas, C. et al. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Aβ42 accumulation in a novel Alzheimer transgenic model. Am. J. Pathol. 165, 1289–1300 (2004). Provides in vivo evidence that intraneuronal Aβ accumulation is toxic and leads to cell death.
  Article CAS PubMed PubMed Central Google Scholar
• Van Broeck, B. et al. Intraneuronal amyloid β and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Neurobiol. Aging 16 Nov 2006 (doi:10.1016/j.neurobiolaging.2006.10.016).
  Article CAS PubMed Google Scholar
• Shie, F. S., LeBoeuf, R. C. & Jin, L. W. Early intraneuronal Aβ deposition in the hippocampus of APP transgenic mice. Neuroreport 14, 123–129 (2003).
  Article CAS PubMed Google Scholar
• Magrane, J. et al. Intraneuronal β-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J. Neurosci. 25, 10960–10969 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Suo, Z. et al. GRK5 deficiency leads to early Alzheimer-like pathology and working memory impairment. Neurobiol. Aging 2 October 2006 (doi: 10.1016/j.neurobiolaging.2006.08.013).
  Article CAS PubMed Google Scholar
• Sugarman, M. C. et al. Inclusion body myositis-like phenotype induced by transgenic overexpression of βAPP in skeletal muscle. Proc. Natl Acad. Sci. USA 99, 6334–6339 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Kitazawa, M., Green, K. N., Caccamo, A. & LaFerla, F. M. Genetically augmenting Aβ42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice. Am. J. Pathol. 168, 1986–1997 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Moussa, C. E. et al. Transgenic expression of β-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology. FASEB J. 20, 2165–2167 (2006).
  Article CAS PubMed Google Scholar
• Echeverria, V. et al. Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the β-amyloid peptide intracellularly in hippocampal and cortical neurons. Neuroscience 129, 583–592 (2004).
  Article CAS PubMed Google Scholar
• Tawil, R. & Griggs, R. C. Inclusion body myositis. Curr. Opin. Rheumatol. 14, 653–657 (2002).
  Article CAS PubMed Google Scholar
• Askanas, V. & Engel, W. K. Inclusion-body myositis: a myodegenerative conformational disorder associated with Aβ, protein misfolding, and proteasome inhibition. Neurology 66, S39–S48 (2006).
  Article CAS PubMed Google Scholar